Germline testing at diagnosis, along with tumor testing, have the potential to identify candidates for investigational poly (ADP-ribose) polymerase (PARP) inhibitors, and updated guidelines call for ...
A presentation Saturday at the National Comprehensive Cancer Network Annual Conference in Orlando, Florida, outlined several key updates for treatment in ovarian cancer based on new studies and ...
These findings support the expansion of germline genetic testing criteria for men with PC. Clinicians should consider incorporating genetic testing for patients who meet these expanded criteria.
Renuka Iyer, M.D., will assume the role of CMO at NCCN, focusing on advancing evidence-based cancer care and guideline ...
The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology have been updated to include duvelisib (Copiktra) as a category 2A treatment option for cutaneous T-cell ...
The National Comprehensive Cancer Network ® (NCCN ®) today announced the publication of new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for Pediatric Hodgkin Lymphoma. Hodgkin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback